Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ackermann

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
New monoclonal antibody (23D12) recognizing three different V gamma elements of the human gamma delta T cell receptor. 23D12+ cells comprise a major subpopulation of gamma delta T cells in postnatal thymusD Kabelitz, T Ackermann, T Hinz, et al.
Journal of General Internal Medicine|January 10, 2009
Effect of advanced access scheduling on processes and intermediate outcomes of diabetes care and utilizationUsha Subramanian, Ronald T Ackermann, Edward J Brizendine, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 1, 2021
Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World PopulationAmisha Wallia, Matthew J O'Brien, David T Liss, et al.
Chemical Science|March 6, 2023
A convenient route to mixed cationic group 13/14/15 compoundsMatthias T Ackermann, Michael Seidl, Riccardo Grande, et al.
The Diabetes Educator|May 30, 2015
The feasibility, acceptability, and preliminary effectiveness of a Promotora-Led Diabetes Prevention Program (PL-DPP) in Latinas: a pilot studyMatthew J O'Brien, Alberly Perez, Victor A Alos, et al.
Journal of General Internal Medicine|April 14, 2018
Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed DiabetesMatthew J O'Brien, Kai McKeever Bullard, Yan Zhang, et al.
American Journal of Preventive Medicine|March 20, 2012
Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspectiveXiaohui Zhuo, Ping Zhang, Elizabeth Selvin, et al.
American Journal of Public Health|September 18, 2015
A Randomized Comparative Effectiveness Trial for Preventing Type 2 DiabetesRonald T Ackermann, David T Liss, Emily A Finch, et al.
American Journal of Health Education|July 19, 2017
Effects of a Community-based Lifestyle Intervention on Change in Physical Activity Among Economically Disadvantaged Adults With PrediabetesLaura M Hays, Helena M Hoen, James E Slaven, et al.
Contemporary Clinical Trials|November 2, 2013
Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: the RAPID StudyRonald T Ackermann, Emily A Finch, Karen K Schmidt, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
New monoclonal antibody (23D12) recognizing three different V gamma elements of the human gamma delta T cell receptor. 23D12+ cells comprise a major subpopulation of gamma delta T cells in postnatal thymusD Kabelitz, T Ackermann, T Hinz, et al.
Journal of General Internal Medicine|January 10, 2009
Effect of advanced access scheduling on processes and intermediate outcomes of diabetes care and utilizationUsha Subramanian, Ronald T Ackermann, Edward J Brizendine, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 1, 2021
Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World PopulationAmisha Wallia, Matthew J O'Brien, David T Liss, et al.
Chemical Science|March 6, 2023
A convenient route to mixed cationic group 13/14/15 compoundsMatthias T Ackermann, Michael Seidl, Riccardo Grande, et al.
The Diabetes Educator|May 30, 2015
The feasibility, acceptability, and preliminary effectiveness of a Promotora-Led Diabetes Prevention Program (PL-DPP) in Latinas: a pilot studyMatthew J O'Brien, Alberly Perez, Victor A Alos, et al.
Journal of General Internal Medicine|April 14, 2018
Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed DiabetesMatthew J O'Brien, Kai McKeever Bullard, Yan Zhang, et al.
American Journal of Preventive Medicine|March 20, 2012
Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspectiveXiaohui Zhuo, Ping Zhang, Elizabeth Selvin, et al.
American Journal of Public Health|September 18, 2015
A Randomized Comparative Effectiveness Trial for Preventing Type 2 DiabetesRonald T Ackermann, David T Liss, Emily A Finch, et al.
American Journal of Health Education|July 19, 2017
Effects of a Community-based Lifestyle Intervention on Change in Physical Activity Among Economically Disadvantaged Adults With PrediabetesLaura M Hays, Helena M Hoen, James E Slaven, et al.
Contemporary Clinical Trials|November 2, 2013
Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: the RAPID StudyRonald T Ackermann, Emily A Finch, Karen K Schmidt, et al.
Pageof 16